Thioctic acid
Japan Standards for Cosmetics: Thioctic acid
The provisional English translation of the MHLW Standards for Cosmetics lists this ingredient with the stated limit or use matrix.
Regulatorische Entscheidung und vollständige Bedingungen
- Status
- Restricted
- Rechtsrolle
- Binding rule
- Regulatorische Zusammenfassung
- The provisional English translation of the MHLW Standards for Cosmetics lists this ingredient with the stated limit or use matrix.
- Bedingungen und Beschränkungen
Published three-column use matrix (rinse-off / leave-on / mucosal; blank means prohibited, ○ means no upper limit): 0.01 0.01
Stoffidentität
- Name in der amtlichen Quelle
- Thioctic acid
- CAS
- 1077-28-7
- EC
- 214-071-2
- Identitätszuordnung
- exact INCI name
- Verknüpfter Inhaltsstoff
- THIOCTIC ACID
Verknüpfte CosIng-Identitätsdaten
Namen und Aliase
CosIng-Beschreibung: 1,2-Dithiolane-3-pentanoic acid, (+/-)-
Erfasste kosmetische Funktion: ANTIOXIDANT
Funktionsseiten:ANTIOXIDANT
Das vollständige Inhaltsstoffprofil ansehenMarktübergreifende Übersicht zu dieser Identität
Exakte verknüpfte Einträge, die derzeit auf dieser Website vorhanden sind. Ein fehlender Markt bedeutet, dass kein exakter Treffer importiert wurde, nicht dass der Stoff verwendet werden darf.
Japan
Aktueller Eintrag1 verknüpfter Eintrag · 1 mit besonderen Bedingungen
Unterstützenden Eintrag öffnen
Verifizierte Chemie für CAS 1077-28-7
alpha Lipoic acid
Lipoic acid is a heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position. It has a role as a geroprotector and a fundamental metabolite. It is a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid. It is functionally related to an octanoic acid. It is a conjugate acid of a lipoate. — ChEBI
- IUPAC-Name
- 5-(dithiolan-3-yl)pentanoic acid
- Summenformel
- C8H14O2S2
- Molekulargewicht
- 206.3 g/mol
- Exakte Masse
- 206.04352203 Da
- Monoisotopische Masse
- 206.04352203 Da
- XLogP3
- 1,7
- Topologische polare Oberfläche
- 87,9 Ų
- Molekulare Komplexität
- 150,0
- Formale Ladung
- 0
- Wasserstoffbrücken-Donoren
- 1
- Wasserstoffbrücken-Akzeptoren
- 4
- Drehbare Bindungen
- 5
- Schweratome
- 12
- Kovalente Einheiten
- 1
An PubChem gemeldete Namen und Synonyme
16 weitere gemeldete Namen
Kennungen in externen Datenbanken
- ChEBI:CHEBI:16494
- ChEMBL:CHEMBL33864
- EPA DTXSID:DTXSID7025508
- PubMed:22654724
- PubMed:22448096
- PubMed:22384101
- PubMed:22374556
- PubMed:22363901
- PubMed:22272085
- PubMed:22242957
- PubMed:22163871
- PubMed:22163517
- PubMed:22146387
- PubMed:22125679
- PubMed:22125537
Erweiterte Strukturstatistik
- Definierte Atom-Stereozentren
- 0
- Nicht definierte Atom-Stereozentren
- 1
- Definierte Bindungs-Stereozentren
- 0
- Nicht definierte Bindungs-Stereozentren
- 0
- 3D-Pharmakophormerkmale
- 5
- 3D-Ringe
- 1
- 3D-Hydrophobe
- 1
- 3D-Akzeptormerkmale
- 2
- 3D-Donormerkmale
- 0
- 3D-Anionenzentren
- 1
- 3D-Kationenzentren
- 0
- 3D-Konformere
- 10
- Effektive 3D-Rotoren
- 6,0
Maschinenlesbare Strukturkennungen
- SMILES
C1CSSC1CCCCC(=O)O- InChI
InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)- InChIKey
AGBQKNBQESQNJD-UHFFFAOYSA-N
Belege aus weiteren wissenschaftlichen Datenbanken
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Forms yellowish flakes Quelle: Hazardous Substances Data Bank (HSDB)
- Dissociation Constants: pKa = 5.10 Quelle: Hazardous Substances Data Bank (HSDB)
- Melting Point: 47.5-48 °C Quelle: Hazardous Substances Data Bank (HSDB)
- Solubility: Yellow powder; solubility in ethanol: 50 mg/mL /Synthetic, oxidized form/ Quelle: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in methanol, ethanol, diethyl ether and chloroform Quelle: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Quelle: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 6.5% (28 of 430) of reports. Quelle: European Chemicals Agency (ECHA)
- Signal: Warning Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (93.5%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (48.6%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (46.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (47%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H411 (46.5%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 430 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 28 of 430 reports by companies.; There are 14 notifications provided by 402 of 430 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Note: This chemical does not meet GHS hazard criteria for 42.3% (52 of 123) of reports. Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (57.7%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (31.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (31.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (31.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H412 (19.5%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 123 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 52 of 123 reports by companies.; There are 7 notifications provided by 71 of 123 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Health Effects: Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, incre Quelle: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: ALA is generally considered a safe drug. A daily dose of 200 mg/day to 2400 mg/day of ALA is deemed safe without significant adverse effects. However, there is no reported safe dose in children.; A notable case in literature demonstrated status epilepticus (SE) that subsided within a few days. The seizures were treated per normal standards for SE.; In the last 2 decades, there have been few reported cases of ALA toxicity in humans. Most of these cases occur in children and are treatable. Though there is no established lethal dosage of ALA for humans, studies have shown that a high dose of 121 mg/kg body weight/day was associated with alterations in liver enzymes and liver function. Therefore, there are potentially harmful adverse effects from overdosing on ALA, and more studies are necessary to determine the toxicity. Quelle: StatPearls
- Toxicity Summary: (R)-lipoic acid is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as Quelle: Toxin and Toxin Target Database (T3DB)
- Uses: Nutrition, biochemical research /Thioctic acid, dl-form/ Quelle: Hazardous Substances Data Bank (HSDB)
- Uses: THERAPEUTIC CATEGORY: Treatment of liver disease; antidote to poisonous mushrooms (Amanita species). Quelle: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >7500; Consumption (g per capita; approx.) in Germany (2009): 0.0916; Calculated removal (%): 96.4 Quelle: NORMAN Suspect List Exchange
- Uses: For nutritional supplementation, also for treating dietary shortage or imbalance. Quelle: Toxin and Toxin Target Database (T3DB)
Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen
Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.
Weitere Quellenabdeckung und Trefferstatus
| Quelle | Ergebnis | Geprüft |
|---|---|---|
| NIH PubChem PUG-View | Exakter Treffer | 2026-08-31 |
Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.
Am 2026-09-02 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.
Amtliche Quelle und Herkunft
- Registrierte Quelle
- Japan MHLW Standards for Cosmetics
- Quellenverweis
- Appendix 2 section 3, entry 2
- Eintrags-ID der Quelle
appendix-2-3:2- Quellenversion
- MHLW Notification No. 331 provisional translation, retrieved 2026-08-30
- Quellsprache
- English provisional translation; Japanese text is canonical
- Übersetzungsstatus
- Regulator-hosted provisional English translation · Englische Übersetzung
- Stand geprüft
- 2026-08-30 04:11 UTC
- Validierungsmethode
- pdftotext -layout plus strict per-table row counts
- SHA-256
117fc949a82789ca66017163f19041cf2fcf6b5902708077c8e4f56c482dc8e2
Hinweise zum registrierten Datensatz
- Datensatzabdeckung
- Prohibited and restricted ingredient appendices with concentration and use conditions
- Hinweis zur Behörde
- Official MHLW standard; validate later Japanese updates before presenting current status
Wie dieser Eintrag in den Marktdatensatz passt
Statusverteilung
Bedingungstext ist bei 117 von 117 aktuellen Einträgen vorhanden. Ein leeres Bedingungsfeld wird entsprechend der oben genannten Eintragsart interpretiert; es wird niemals in die Aussage einer uneingeschränkten Verwendung umgedeutet.
Japan Marktkontext
Complete Standards appendices dataset
Abdeckungsversion: MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
Prohibited ingredients, restricted ingredients and permitted preservative/UV/colourant appendices present in the official standard source.
Verifizierungs-Checkliste
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
Amtliche Marktquellen
- Japan MHLW Standards for CosmeticsOfficial MHLW standard; validate later Japanese updates before presenting current status
Verifizierungsablauf und Vollständigkeit des Eintrags
Bevor Sie dieses Ergebnis für eine Compliance-Entscheidung verwenden
- Bestätigen Sie, dass „Thioctic acid“ und jede CAS-/EC-Kennung sich auf das Material in Ihrer Lieferantenspezifikation beziehen.
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
- Dokumentieren Sie die Quellenversion und prüfen Sie die Behörde vor Herstellung, Notifizierung oder Inverkehrbringen erneut.
In diesem Eintrag verfügbare Felder
- Amtlicher StoffnameVerfügbar
- CASVerfügbar
- ECVerfügbar
- Gesonderter BedingungstextVerfügbar
- Datum des InkrafttretensNicht angegeben
- Snapshot-Hash und MethodeVerfügbar
Fragen, die diese Seite beantwortet
Dauerhafte Zitierweise
Thioctic acid. Appendix 2 section 3, entry 2. Japan. Source version MHLW Notification No. 331 provisional translation, retrieved 2026-08-30. CosIng Checker regulatory record: https://cosingchecker.com/de/regulations/jp/records/633/
Zitieren Sie die Aufsichtsbehörde als rechtliche Autorität. Diese Seite ist ein strukturierter Belegindex und eine Verifizierungshilfe, kein Ersatz für den amtlichen Text oder eine fachkundige rechtliche Bewertung.
Auslegung und Grenzen für Japan
This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.
Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.
Wie die Rechtsrolle auszulegen ist
The cited row forms part of a binding rule or legally incorporated list for this market.
Belege auf dieser Seite
- Erfasstes Ergebnis: Restricted
- Rechtsrolle: Binding rule
- Quellenversion: MHLW Notification No. 331 provisional translation, retrieved 2026-08-30
Was es nicht beweist
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
Weitere maßgebliche Stoffrecherche
Keine dieser Quellen hebt die oben genannte Marktentscheidung auf.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Diese Identität bei der Quelle recherchierenFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Diese Identität bei der Quelle recherchierenILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Diese Identität bei der Quelle recherchierenJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Diese Identität bei der Quelle recherchierenNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Diese Identität bei der Quelle recherchierenOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Diese Identität bei der Quelle recherchierenUS EPA CompTox CTX APIs
Für den Import ist ein API-Schlüssel erforderlichDTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Diese Identität bei der Quelle recherchieren